MedPath

Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)

Not Applicable
Recruiting
Conditions
Mental Health Disorder
Interventions
Behavioral: Attentional Placebo Control
Behavioral: Systems Analysis and Improvement Approach for Mental Health (SAIA-MH)
Registration Number
NCT05103033
Lead Sponsor
University of Washington
Brief Summary

The purpose of this study is to test the effectiveness of a multicomponent implementation strategy entitled the Systems Analysis and Improvement Approach for mental health (SAIA-M) using a cluster randomized trial at the health facility level. SAIA-MH focuses on improving the mental health treatment cascade in primary outpatient mental healthcare. The mental health treatment cascade is a model that outlines the sequential, linked treatment steps that people with mental illness must navigate, from initial diagnosis to symptom/function improvement.

This study will also assess the potential mechanisms by which the SAIA-MH implementation strategy works, or does not work, along with the cost and effectiveness of scaling-up SAIA-MH in Mozambique.

Detailed Description

Due to a shortage of 1.2 million mental health (MH) workers across low- and middle-income countries (LMICs), academic and policy leaders have advocated scaling-up task-sharing to lower-level providers to close the mental health care gap, which exceeds 90% in many LMICs. While task-sharing may increase access to care, limited attention has been paid to quality of care provided by lower-level providers. Task-shared outpatient management of mental health in Mozambique has shown low rates of retention in care (40%), medication adherence (\<15%), and proportion of patients achieving function improvement (\<5%). Similarly high rates of loss-to-follow-up, poor adherence, and poor patient outcomes have been reported across other LMICs. To our knowledge, there are no evidence-based implementation strategies targeting optimization of the MH treatment cascade in low-resource settings. This is an urgent need for the field of MH care delivery globally.

The MH treatment cascade is a model that outlines the sequential, linked treatment steps that people with mental illness must navigate, from initial diagnosis to symptom/function improvement. Quality problems in one step of a treatment cascade can have non-linear and compounding impacts across the larger complex care system. Implementation strategies focused on only one step in a cascade can potentially contribute to unintended system bottlenecks and quality of care issues. By contrast, the "Systems Analysis and Improvement Approach (SAIA)" is a multicomponent implementation strategy focused on optimizing an entire treatment cascade. SAIA blends facilitation, enhanced local clinical consultation, and the creation of facility-level learning collaboratives with systems-engineering tools in a 5-step approach specifically developed for task-shared providers, which include: (1) cascade analysis to visualize treatment cascade drop-offs and prioritize areas for system improvements; (2) process mapping to identify modifiable facility-level bottlenecks; (3) identification and implementation of modifications to improve system performance; (4) assessment of modification effects on the cascade; and (5) repeated analysis and improvement cycles. A previous cluster RCT established effectiveness of SAIA for HIV treatment cascade improvement (R01HD075057; PI: Sherr). However, no effectiveness data exist on SAIA applied to other complex treatment cascades - such as task-shared MH care. Preliminary data suggest that applying SAIA to MH treatment cascade optimization (SAIA-MH; R21MH113691; PI: Wagenaar) is feasible, acceptable, and can result in clinically-significant treatment cascade improvements; Five months of SAIA-MH implementation resulted in a 1.5-fold increase in medication adherence (aOR: 1.5; CI: 1.2, 1.9) and a 3.7-fold increase in function improvement (aOR: 3.7; CI: 2.5, 5.4). These data suggest that SAIA-MH is a promising strategy for task-shared MH systems improvement globally. Our specific aims are to:

Primary Aim 1: Test the effectiveness of the SAIA-MH strategy using a pragmatic cluster RCT design and assess determinants of implementation success. The investigators will implement SAIA-MH using a 3-year parallel cluster RCT across 8 intervention and 8 attentional control facilities and evaluate effects on mental health function improvement (primary) and retention / medication adherence (secondary). Two years of study implementation will be followed by a 1-year maintenance phase to examine routine fidelity and sustainability. The Consolidated Framework for Implementation Research (CFIR) will be used to assess determinants of implementation success.

Secondary Aim 1: Test causal pathway models to analyze mechanisms of action for effects (or non-effects) of the SAIA-MH implementation strategy. Using 3-years of monthly data on strategy-mechanism linkages, moderators, preconditions, and outcomes for the full 8 intervention and 8 attentional control facilities, the investigators will examine causal pathway effect estimates using longitudinal structural equation modeling. Qualitative CFIR data from Primary Aim 1 will contextualize quantitative path analyses.

Specific Aim 2: Estimate the cost and cost-effectiveness of scaling-up SAIA-MH in Mozambique. The investigators will conduct micro-costing and time-and-motion observation of the SAIA-MH RCT to estimate costs of implementing the intervention. The investigators will construct a Markov model parameterized with cost and outcome data from the SAIA-MH RCT to project budget impact and cost-effectiveness for SAIA-MH scale-up to provincial and national levels.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
155
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Attentional Placebo ControlAttentional Placebo ControlControl facilities will mimic activities of the intervention group in time and contacts, but without the "active ingredient" of the SAIA-MH implementation strategy
Systems Analysis and Improvement Approach (SAIA) for mental healthSystems Analysis and Improvement Approach for Mental Health (SAIA-MH)Those receiving SAIA-MH will attend a 1-week in-person training for facility learning collaboratives. Following the 1-week in-person training, SAIA-MH standard operating procedures will be implemented, including: (1) structured internal/external facilitation following tablet-based guides used in pilot study (1x per week first month; 2x per week for next two months; 1x per month for remainder); (2) facilitation in the 5-step SAIA-MH improvement process.
Primary Outcome Measures
NameTimeMethod
Patient Function Improvementdata collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

Patient function improvement is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. All patients diagnosed with a mental disorder in target clinics will have function improvement measured by the WHODAS 2.0 at each clinic visit.

Improvement will be determined as patients with at least 1 follow-up visits who score less than or equal to 10 on the WHODAS 2.0 or have a 50% reduction in their baseline WHODAS 2.0 score.

Secondary Outcome Measures
NameTimeMethod
Patient Retentiondata collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

Patient retention is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. This outcome evaluates whether these individuals returned for their scheduled follow-up visit in less than or equal to 30 days.

Patient Medication Adherencedata collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

Medication adherence is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. These patients are considered to have potentially achieved medication adherence if they return for their follow-up visit and medication refill in less days than they had pills dispensed at their previous visit.

Trial Locations

Locations (16)

Urban Health Center Mascarenhas

🇲🇿

Beira, Sofala, Mozambique

District Hospital Catandica

🇲🇿

Catandica, Manica, Mozambique

Urban Health Center Nhamaonha

🇲🇿

Chimoio, Manica, Mozambique

Urban Health Center Chingussura

🇲🇿

Beira, Sofala, Mozambique

Urban Health Center Vila Nova

🇲🇿

Chimoio, Manica, Mozambique

District Hospital Gondola

🇲🇿

Gondola, Manica, Mozambique

Urban Health Center Inhamizua

🇲🇿

Beira, Sofala, Mozambique

Rural Health Center Sussundenga Sede

🇲🇿

Sussundenga, Manica, Mozambique

Rural Health Center Vanduzi

🇲🇿

Vanduzi, Manica, Mozambique

Rural Health Center Macate

🇲🇿

Macate, Manica, Mozambique

Urban Health Center Macurungo

🇲🇿

Beira, Sofala, Mozambique

Hospital Muxúngue

🇲🇿

Chibabava, Sofala, Mozambique

Rural Health Center Mafambisse

🇲🇿

Dondo, Sofala, Mozambique

District Hospital Manica

🇲🇿

Manica, Mozambique

Urban Health Center Dondo Sede

🇲🇿

Dondo, Sofala, Mozambique

Rural Hospital Nhamatanda

🇲🇿

Nhamatanda, Sofala, Mozambique

© Copyright 2025. All Rights Reserved by MedPath